Page last updated: 2024-10-30

leflunomide and Acidosis, Renal Tubular

leflunomide has been researched along with Acidosis, Renal Tubular in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Acidosis, Renal Tubular: A group of genetic disorders of the KIDNEY TUBULES characterized by the accumulation of metabolically produced acids with elevated plasma chloride, hyperchloremic metabolic ACIDOSIS. Defective renal acidification of URINE (proximal tubules) or low renal acid excretion (distal tubules) can lead to complications such as HYPOKALEMIA, hypercalcinuria with NEPHROLITHIASIS and NEPHROCALCINOSIS, and RICKETS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Evans, SJ1
Webb, D1
Lawson, TM1
Siebert, S1

Other Studies

1 other study available for leflunomide and Acidosis, Renal Tubular

ArticleYear
Renal tubular acidosis associated with leflunomide.
    Rheumatology (Oxford, England), 2007, Volume: 46, Issue:6

    Topics: Acidosis, Renal Tubular; Adult; Antirheumatic Agents; Arthritis; Female; Humans; Isoxazoles; Lefluno

2007